logo

Ani Pharmaceuticals, Inc. (BPAX)



Trade BPAX now with
  Date
  Headline
6/5/2018 8:31:16 AM ANI Shareholders Elect Three Members To Board
5/8/2018 8:31:37 AM ANI Pharma Q1 GAAP EPS $0.19 Vs $0.10 Last Year
5/7/2018 8:31:23 AM ANI Pharmaceuticals Completes Acquisition Of Generic Products And Assets From Amneal/Impax
4/27/2018 7:32:44 PM ANI Pharmaceuticals Signs Definitive Agreements To Acquire Generic Products And Assets From Amneal/Impax
4/18/2018 8:32:52 AM ANI Gets FDA Approval For Its ANDA For Morphine Sulfate Oral Solution 10mg/5mL, 20mg/5mL And 100mg/5ml
4/4/2018 8:32:53 AM ANI Acquires ANDAs For 23 Previously Marketed Generic Drug Products From IDT Australia
2/27/2018 8:34:11 AM ANI Pharmaceuticals Q4 GAAP Loss Per Share $0.83; Adjusted Non-GAAP EPS $1.08
11/2/2017 9:07:47 AM ANI Pharmaceuticals, Inc. (ANIP) Has Raised Its 2017 EPS Estimate To 3.83 - 4.00 From 3.58 - 3.94
11/2/2017 9:06:55 AM ANI Pharmaceuticals, Inc. (ANIP) Has Lowered Its 2017 Revenue Estimate To $181 - $183 Mln From $181 - $190 Mln
11/2/2017 8:31:41 AM ANI Pharmaceuticals Q3 Net Revenues Up 25% To $48.2 Mln